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Prolactin-releasing peptide (PrRP) is a recently discovered neuropeptide implicated in the
central control of feeding behaviour and autonomic homeostasis. PrRP-containing neurones
and PrRP receptor mRNA are found in abundance in the caudal portion of the nucleus tractus
solitarius (NTS), an area which together with the dorsal motor nucleus of the vagus (DMV)
comprises an integrated structure, the dorsal vagal complex (DVC) that processes visceral
afferent signals from and provides parasympathetic motor innervation to the gastrointestinal
tract. In this study, microinjection experiments were conducted in vivo in combination with
whole-cell recording from neurones in rat medullary slices to test the hypothesis that PrRP
plays a role in the central control of gastric motor function, acting within the DVC to modulate
the activity of preganglionic vagal motor neurones that supply the stomach. Microinjection of
PrRP (0.2 pmol (20 nl)−1) into the DMV at the level of the area postrema (+0.2 to +0.6 mm
from the calamus scriptorius, CS) markedly stimulated gastric contractions and increased
intragastric pressure (IGP). Conversely, administration of peptide into the DMV at sites caudal
to the obex (0.0 to –0.3 mm from the CS) decreased IGP and reduced phasic contractions. These
effects occurred without change in mean arterial pressure and were abolished by ipsilateral
vagotomy, indicating mediation via a vagal-dependent mechanism(s). The pattern of gastric
motor responses evoked by PrRP mimicked that produced by administration of L-glutamate
at the same sites, and both the effects of L-glutamate and PrRP were abolished following local
administration of NMDA and non-NMDA-type glutamate receptor antagonists. On the other
hand, microinjection of PrRP into the medial or comissural nucleus of the solitary tract (mNTS
and comNTS, respectively) resulted in less robust changes in IGP in a smaller percentage of
animals, accompanied by marked alterations in arterial pressure. Superfusion of brain slices
with PrRP (100–300 nM) produced a small depolarization and increased spontaneous firing in
10 of 30 retrogradely labelled gastric-projecting DMV neurones. The excitatory effects were
blocked by administration of TTX (2 µM) or specific glutamate receptor antagonists, indicating
that they resulted from interactions of PrRP at a presynaptic site. Congruent with this, PrRP
increased the amplitude of excitatory postsynaptic currents (EPSCs, 154 ± 33%, 12 of 25
neurones) evoked by electrical stimulation in mNTS or comNTS. In addition,
administration of PrRP decreased the paired-pulse ratio of EPSCs evoked by two identical
stimuli delivered 100 ms apart (from 0.95 ± 0.08 to 0.71 ± 0.11, P < 0.05), whereas it did not
affect the amplitude of inward currents evoked by exogenous application of L-glutamate to the
slice. The frequency, but not amplitude of spontaneous EPSCs and action potential-independent
miniature EPSCs was also increased by administration of PrRP, suggesting that the peptide was
acting at least in part at receptors on presynaptic nerve terminals to enhance glutamatergic
transmission. In recordings obtained from a separate group of slices, we did not observe any
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direct effects of PrRP on spontaneous discharge or postsynaptic excitability in either mNTS or
comNTS neurones (n = 31). These data indicate that PrRP may act within the DVC to regulate
gastric motor function by modulating the efficacy of conventional excitatory synaptic inputs
from the NTS onto gastric-projecting vagal motor neurones.
Prolactin-releasing peptide (PrRP) is a recently discovered
neuropeptide, originally identified as the endo-
genous ligand for the human orphan G protein-coupled
receptor UHR-1 (Hinuma et al. 1998). Although initially
named for its ability to stimulate prolactin secretion in
cultured anterior pituitary cells, central administration of
PrRP has since been shown to cause the secretion of other
hypothalamic-pituitary hormones, including oxytocin,
adrenocorticotropin, luteinizing and follicle-stimulating
hormone (Maruyama et al. 1999a; Seal et al. 2000).
However, the absence of immunoreactivity for PrRP in the
median eminence in rats (Maruyama et al. 1999b), coupled
with the restricted pattern of PrRP mRNA expression
found in the brain, argue against its role as a classic
hypophysiotropic hormone.
Anatomical studies indicate that PrRP is synthesized
by neurones localized exclusively in three regions in the
brain, the caudal portion of the hypothalamic dorso-
medial nucleus, the nucleus tractus solitarius (NTS) and
the ventrolateral medullary reticular formation (Roland
et al. 1999; Ibata et al. 2000; Lee et al. 2000), areas
implicated in the control of appetite and autonomic
regulation. Within the brain stem, PrRP-immunopositive
perikarya are restricted to the caudal part of the
NTS and to an area corresponding to the ventro-
lateral reticular nucleus, appearing as dense clusters that
account, respectively, for approximately 70% and 25%
of all central PrRP-containing neurones. In addition,
all of the PrRP-immunoreactive neurones within these
brainstem areas were found to coexpress immuno-
reactivity for tyrosine hydroxylase (TH), identifying them
as belonging to the A2 and A1 catecholaminergic cell
groups, respectively (Chen et al. 1999; Yano et al. 2001).
Results obtained from immunohistochemical mapping
studies reveal that PrRP neurones provide a diffuse
network of axonal projections to various parts of the
brain and spinal cord (Chen et al. 1999; Maruyama et al.
1999b). On the other hand, mRNA encoding for PrRP
receptors is localized to specific brain areas and nuclei,
being abundantly expressed in the periventricular and
dorsomedial hypothalamus, reticular thalamic nucleus,
NTS, area postrema (AP) and anterior pituitary (Roland
et al. 1999; Lee et al. 2000), suggesting a more limited scope
of action for the peptide in the brain.
The highest levels of PrRP protein and the strongest
expression of message-encoding PrRP receptors have
been reported in the caudal NTS, indicating that the
peptide may be involved in modulating activity within this
autonomic relay nucleus (Roland et al. 1999). The NTS is
the major recipient of visceral afferent information arising
from various regions of the gastrointestinal (GI) tract.
Neurones located in the caudal two-thirds of the nucleus,
including the A2 catecholamine-containing cells (Sumal
et al. 1983; Rinaman et al. 1995), relay signals concerning
satiety and prandial stimuli conveyed via vagal afferents
to more rostral brain sites and provide a major site for
their integration with descending commands originating
from autonomic centres of the hypothalamus and
forebrain. The NTS neurones also provide direct inhibitory
and excitatory inputs to preganglionic parasympathetic
neurones in the DMV that in turn control gastric motility
and secretion via their efferent projections in the vagus
nerve (Rogers et al. 1996; Rogers et al. 1999). By way
of these interconnections, the NTS and dorsal motor
nucleus of the vagus (DMV) comprise a functionally
integrated structure, termed the dorsal vagal complex
(DVC), providing the synaptic circuitry responsible for
the coordination of classic vago-vagal GI reflexes. The
vast majority of NTS neurones utilize either GABA or
glutamate as their neurotransmitter, and it is generally
accepted that their inhibitory and excitatory effects on
the excitability of DMV neurones are mediated directly
via activation of postsynaptic GABAA receptors and both
NMDA- and non-NMDA-type glutamatergic receptors,
respectively (Travagli et al. 1991; Willis et al. 1996).
However, DMV neurones also receive synaptic input from
catecholamine-containing NTS neurones, corresponding
to the A2 cell group (Fukuda et al. 1987). The activation
of inputs from the latter group of cells has been shown
to modulate the activity of vagal efferent neurones,
producing both excitation and inhibition via interactions
of noradrenaline (norepinephrine) with postsynaptic
receptors on DMV neurones, as well as at presynaptic sites
(Fukuda et al. 1987; Bertolino et al. 1997). Interestingly, a
large percentage (67%) of these catecholaminergic NTS
neurones express immunoreactivity for PrRP (Ellacott
et al. 2002), although it is not known whether and how
this peptide might affect DMV neurone activity.
The aim of the present study was to examine the
hypothesis that PrRP functions in the central control of
gastric activity, acting within the DMV and/or by way
of the NTS to modulate vagal efferent outflow to the
upper GI tract. To test this hypothesis, we made use
of two complementary experimental approaches. Micro-
injection experiments were conducted in anaesthetized
rats to investigate the effects of administration of PrRP
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into the DMV or NTS (medial and comissural subnuclei)
on gastric tone and motility. In addition, whole-cell
patch-clamp recordings were performed in rat brainstem
slices to determine the effects of PrRP on the resting
membrane properties and synaptically evoked current
responses of gastric-projecting vagal motor neurones, and
on postsynaptic excitability of NTS neurones. In this study,
we demonstrate that PrRP acts within the DVC to regulate
gastric motor function and provide electrophysiological
evidence that it alters vagal efferent outflow to the stomach
by modulating excitatory synaptic input from the NTS
onto gastric-projecting DMV neurones.
Methods
Animal preparation and microinjection studies in vivo
Experiments were performed on adult male
Sprague-Dawley rats (250–350 g), obtained from
Charles River Laboratories (Wilmington, MA, USA),
in accordance with NIH guidelines and as approved by
the University of Michigan Health Center Institutional
Animal Care and Use Committee.
Prior to experimentation, animals were fasted overnight
with ad libitum access to water. Anaesthesia was induced
in the animals with urethane (1.0–1.25 g kg−1 i.p) and
its depth monitored by assessing for the absence of limb
withdrawal to a noxious toe pinch. Body temperature was
monitored by a rectal probe and maintained at 37 ± 1◦C
by means of a homeothermic pad placed under the
animal. Following the induction of anaesthesia, silicon
catheters were inserted into the femoral artery and vein
for monitoring arterial blood pressure and drug infusion,
respectively. A laparotomy was then performed to expose
the stomach. In some experiments, the vagus nerves were
carefully exposed along their cervical extent, and ligatures
were tied around one or both nerves, after which the area
was moistened with mineral oil. An intragastric balloon,
fashioned from the little finger of a small latex glove, was
tied around polyethylene tubing (PE 160) and inserted into
the stomach via a small incision placed in the pylorus to
obtain measurements of intragastric pressure (IGP). The
balloon was secured with a running suture to prevent
movement and the incision made in the pylorus was
closed. The tubing was connected to a pressure trans-
ducer, interfaced to a bridge amplifier, whose signal was fed
into an analog-to-digital converter (MacLab System, A-D
Instruments, Grand Junction, CO) and the data stored
on a microcomputer for subsequent analysis off-line. The
stomach was inflated by introducing 2–3 ml of warm
saline into the intragastric balloon to achieve a baseline
pressure of ∼5 cm H2O that was used for all micro-
injection experiments.
The animal was then positioned in a stereotaxic
apparatus, and a partial craniotomy was performed to
expose the dorsal surface of the medulla. The cerebellum
was retracted slightly and a slit made in the subarachnoid
covering to expose the fourth ventricle. The calamus
scriptorius (CS), representing the caudal-most pole of
the area postrema, was viewed from the dorsal aspect
and used as a point of reference for the stereotaxic
placement of multibarrel glass micropipette assemblies
into the DMV or NTS. For the purposes of this study,
the DMV was divided into rostral and caudal regions
based on its anatomical relationship with the area
postrema (Loewy, 1990). The portion of the DMV
extending roughly from the CS to the anterior border
of the area postrema was defined as the ‘rostral
DMV, and the portion of the nucleus extending
caudal from the CS was defined as the ‘caudal
DMV’. Microinjection of drug was performed by
pneumatic pressure delivered via a pico-pump (model
PV-830, World Precision Instruments, Sarasota, FL,
USA) to individual barrels containing solutions of
PrRP, l-glutamate, 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX), d-22-amino-5-phosphopentanoic acid (AP5) or
saline. An additional saline-filled barrel also contained
fluorescein-labelled fluorescent microbeads (Polysciences,
Eppelheim, Germany) that were used for marking of the
injection site. At the end of an experiment, rats were killed
with an overdose of urethane, perfused transcardially with
a mixture of 4% paraformaldehyde in phosphate-buffered
saline, and the brains removed and placed in fixative for
at least 24 h. Coronal sections of 50 µm thickness were
cut through the brainstem, counterstained with neutral
red, and then examined under a fluorescent microscope
equipped with FITC filters to confirm the location of the
injection site.
All microinjections were delivered unilaterally, unless
indicated otherwise in the text. Injections were given in
volumes of 20 nl over a period of 10–15 s. Stereotaxic
coordinates were originally chosen based on histological
material presented in Paxinos & Watson (1986). Final
coordinates for placement of the electrode tip within
the rostral DMV (coordinates: 0.2–0.6 mm rostral to the
CS, respectively, 0.3–0.6 mm lateral from the midline,
and 0.5–0.7 mm ventral from the dorsal surface of the
medulla) were selected based on preliminary experiments
wherein microinjection of l-glutamate (4 nmol) produced
transient elevations in IGP (see below). Conversely,
coordinates for placements within the caudal DMV
(coordinates: 0.0 mm to 0.3 mm caudal from the CS,
0.3–0.5 mm lateral from the midline, and 0.6–0.8 mm
ventral from the dorsal surface of the medulla)
were determined from sites where similar injections
of l-glutamate evoked gastric relaxation (see below).
Coordinates for the medial and comissural nuclei of
the solitary tract (mNTS and comNTS) were similarly
determined from micropipette placements wherein
microinjection of l-glutamate (4 nmol) induced gastric
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relaxations and ranged from 0.2 to 0.5 mm rostral and
0.0 to 0.3 mm caudal to the CS, respectively, 0.5–0.7 mm
lateral from the midline, and from 0.4 to 0.6 mm from
the dorsal surface of the medulla. For experiments in
which glutamate receptor antagonists were administered,
CNQX and AP5 were co-applied at doses (200 pmol and
2 nmol, respectively) that were determined in pilot studies
to effectively block gastric motor responses evoked by a
single bolus injection of l-glutamate (4 nmol) into the
DMV.
Analysis of microinjection data
Data from IGP measurements were analysed using the
Chart Software analysis program designed for the MacLab
data acquisition system (AD Instruments). Prior to
initiation of microinjections, values were calculated over
a 5 min control period during which the baseline in
the IGP trace remained stable. The lowest points of
the IGP trace obtained over that 5 min segment were
averaged, and the resultant value used as an index
of gastric tone. After microinjections of drug into the
DMV or NTS, the maximum or minimum value in
the IGP trace (also derived from a 5 min segment) was
taken as the largest change in gastric tone. The peak
increases and decreases in IGP were compared with the
pre-injection baseline levels, and drug-induced changes in
IGP reported as means of the absolute value of change
in IGP ± s.e.m. Differences between groups were assessed
by one-way ANOVA followed by student Newman-
Keuls multiple-comparisons test. Effects were considered
to be statistically different compared to vehicle at
P-values < 0.05
Retrograde labelling
Sprague-Dawley rats (10 days old) of either sex were
deeply anaesthetized via inhalation of a 4% solution
of 2-bromo-2-chloro-1,1,1-trifluorethane (Halothane,
Sigma Chemical) in air (500 ml min−1) before abdominal
surgery was performed. The depth of anaesthesia was
assessed by absence of the limb withdrawal reflex
to noxious foot pinch and maintained throughout
surgical procedures by placing the head of the rat
in a custom-made chamber through which a 2%
halothane–air mixture was continuously delivered. The
abdominal area was cleaned with 70% ethanol and a
laparotomy performed. Crystals of the retrograde tracer
1.1′-dioctadecyl-3,3,3′,3-tetramethylindocarbocyanine
perchlorate (DiIC18, Molecular Probes, Eugene, OR, USA)
were applied to the serosal surface of the gastric corpus
(along the greater curvature) according to procedures
developed by Browning et al. (1999). To confine
the dye to the site of application, the application site
was embedded in a fast-hardening epoxy resin that was
allowed to harden (3–5 min) before the surgical area was
washed with warm sterile saline solution and blotted
dry with cotton swabs. The wound was closed using
5/0 nylon sutures, after which the rats were placed in a
chamber warmed to 36◦C under a radiant heat lamp,
until normal motor activity was restored. Animals were
then returned to their home cage and allowed to recover
for 7–15 days before being used for electrophysiological
study.
Brain slice preparation
Coronal tissue slice preparations of the caudal brain-
stem were prepared according to procedures previously
described (see Grabauskus & Moises, 2003). Briefly, rats
were rapidly decapitated and the whole brain carefully
removed and placed in ice-cold physiological saline
containing (mm) NaCl, 124; KCl, 2.5; CaCl2, 2.5; MgSO4,
1.3; NaHCO3, 26; NaH2PO4, 1.25; and glucose, 10,
pregassed with 95% O2–5% CO2 and adjusted to pH
7.3. The cerebellum was removed and the brainstem
was transected rostrally at the level of the pons and
again at a point several millimetres caudal to the CS.
Using a vibratome (Ted Pella, Redding, CA, USA),
coronal brain sections containing the DVC were cut
at 200 µm thickness and placed in a holding chamber.
Following at least 1 h for equilibration, a single slice
was then transferred to a custom-designed recording
chamber (volume of ∼1 ml) and held in place by a
nylon mesh, submerged under continuously flowing
(1–2 ml min−1) oxygenated physiological saline at either
room temperature (current-clamp recordings) or warmed
to 34◦C (voltage-clamp recordings).
Electrophysiological recordings
Prior to electrophysiological recording, retrogradely
labelled DMV neurones were identified using a Nikon
E600FN (Nikon, Melville, NY) microscope equipped with
Nomarski optics and epifluorescent filters suitable for
visualizing DiI. The DVC was briefly exposed to fluorescent
light using TRITC filters to visualize the fluorescent
neurone(s), and once the labelled neurone was identified,
its location in the slice was confirmed under bright field
illumination using DIC (Nomarski) optics. Stimulating
and recording electrodes were then placed into position
under visual guidance and whole-cell recordings obtained
under brightfield illumination.
Whole-cell patch-clamp recordings were performed
using patch pipettes (4–5 M), pulled in two stages
from 1.5 mm o.d. borosilicate filament glass and filled
with a solution containing (mm): K-gluconate, 120;
KCl, 10; Hepes, 10; EGTA, 10; MgCl2, 1.0; CaCl2, 1.0;
ATP, 2.0; GTP, 0.5. The recording pipette solution was
adjusted to pH 7.2–7.3 with KOH and had an osmolarity
of 275–292 mosmol. Recordings were obtained from
DMV neurones that were unequivocally labelled with
DiI and from a smaller number of undefined neurones
in the mNTS or comNTS. The data were recorded under
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voltage- or current-clamp conditions using an Axopach
1D amplifier (Axon instruments, Union City, CA, USA).
Data were sampled every 100 µs and filtered at 3 kHz,
digitized via an A/D converter (Digidata 1200C, Axon
Instruments, Union City, CA, USA) interfaced to a
Pentium-based microcomputer, and stored for subsequent
analysis off-line. Data acquisition, storage and analysis
were performed using pCLAMP software (ver.8 and 9,
Axon Instruments, Union City, CA, USA). Records were
corrected for a tip potential of approximately 8 mV and
were accepted only if series resistance was < 15 M.
Excitatory and inhibitory postsynaptic currents (EPSCs
and IPSCs, respectively) were evoked by stimulating the
mNTS or comNTS, using rectangular constant current
pulses (0.5 ms duration) delivered via a tungsten bipolar
stimulating electrode (World Precision Instruments,
Sarasota, FL, USA). Single shocks or pairs of stimuli
(spaced 100 ms apart) were delivered every 30 s, and the
stimulus intensity was adjusted to evoke submaximal
(∼65% of maximal) postsynaptic currents (PSCs) that
ranged in amplitude from 35 to 350 pA when recording in
control medium. The criteria for detecting spontaneous
synaptic currents were fast rise times (<1 ms) and
exponential decays, with 20 pA (at least twice baseline
noise) used as the detection limit for minimum EPSC
amplitude. Frequencies of spontaneous synaptic events
were obtained over continuous periods of recording
lasting from 2 to 6 min, and between 100 and 300
consecutive PSCs were measured for determinations of
mean amplitudes.
Data and statistical analysis
Recordings were considered acceptable if the neuronal
resting membrane potential was more negative than
−50 mV, and the neurone generated overshooting action
potentials. In addition, variability in amplitude of
NTS-evoked synaptic currents was required to be within
10% between trials during control for neurones to be
included in the analysis. Data were expressed as means
(s.e.m). Statistical analysis was performed using ANOVA
paired tests and the significance was accepted at the
level P < 0.05. Analysis of PSC frequency and amplitudes
was conducted with Clampfit subroutines available with
PClamp version 9 software. This program detects and
measures spontaneous synaptic events by application of
various user-defined criteria, including the amplitude,
waveform, duration and area under the curve (fc).
Statistical comparisons of the extracted amplitude and
interspike interval distributions for PSCs were obtained
using the non-parametric Kolmogorov–Smirnov test, with
a significant difference being set at P < 0.01.
Drug application
Drugs were applied to the bath in known concentrations
via a series of manually operated switching valves. Because
of the long duration of effects encountered with PrRP,
superfusion of the peptide was terminated once a plateau
effect was observed. When experiments were performed
to determine concentration–response relationships, the
subsequent superfusion of different concentrations of
peptide was randomized and a washout period of at least
30 min was allowed between individual trails. Recordings
of stimulation-evoked EPSCs were carried out in the
presence of bicuculline methiodide (BMI, 30 µm) or
picrotoxin (100 µm) to selectively eliminate spontaneous
and evoked GABAergic IPSCs (Browning et al. 1999).
Administration of these antagonists at the concentrations
indicated has been shown previously to eliminate
spontaneous and evoked GABA-mediated currents in
DMV neurones, without affecting glutamate-mediated
excitatory synaptic events (Willis et al. 1996; Bertolino et al.
1997). For all experiments with electrically evoked PSCs,
a minimum of 10 control EPSC responses were obtained
prior to application of drug, and the effects were assessed
using each neurone as its own control, i.e. the results
obtained after administration of a receptor antagonist or
peptide were compared to those obtained before drug
administration.
PrRP (12–31) was purchased from Bachem, DiIC18
was purchased from Molecular Probes (Eugene,
OR, USA), and tetrodotoxin (TTX) was purchased
from Alamone Laboratories (Jerusalem, Israel).
6-Cyano-7-nitroquinoxaline-2,3-dione disodium
(CNQX), dl-2-amino-7-phosphonoheptanoic acid
(APV), dl-2-amino-5-phosphonopentanoic acid (AP5)
(–)-bicuculline methiodide (BMI) and other chemicals
were purchased from Sigma-Aldrich-RBI (St. Louis, MO,
USA).
Results
Effects of PrRP on gastric tone and motility
Figure 1 illustrates representative IGP recordings of the
gastric motor responses produced by microinjection
of l-glutamate (4 nmol in 20 nl) or PrRP (2 pmol in
20 nl) at sites within rostral (upper trace) and caudal
portions (lower trace) of the DMV. Microinjection
of l-glutamate into the DMV at the level of the area
postrema evoked transient increases in IGP (2.1 ± 0.3 cm
H2O, 2.8 ± 1.1 min duration, n = 9, P < 0.0.05),
accompanied by little or no changes in mean arterial
pressure (Fig. 1A, upper trace). Such responses have been
attributed to the excitation of vagal neurones that stimulate
gastric contraction via activation of cholinergic post-
ganglionic enteric neurones (Rossiter et al. 1990; Krowicki
et al. 2002). By contrast, microinjection of l-glutamate
into the DMV at sites 0–0.3 mm caudal to the CS decreased
baseline IGP (−1.8 ± 0.4 cm H2O, 3.8 ± 1.5 min duration,
n = 9, P < 0.05) and inhibited phasic contractions
(Fig. 1B, upper trace), independent of changes in
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mean arterial pressure. The glutamate-induced gastric
relaxation is thought to result from the activation
of vagal neurones that synapse onto postganglionic
inhibitory non-adrenergic, non-cholinergic intragastric
motor neurones (Rossiter et al. 1990; Krowicki et al.
2002). Changes in IGP were not observed following
microinjection of saline (20 nl) into the DMV at sites
in which administration of l-glutamate produced
stimulation (n = 8) or reductions (n = 9) in gastric tone
or phasic contractions.
Figure 1. Representative chart recordings showing the effect of microinjection of glutamate
(4 nmol (20 nl)−1) or PrRP (2 pmol (20 nl)−1) into the rostal (A) and caudal (B) DMV on IGP and arterial
blood pressure (BP)
A, microinjection of L-glutamate into the DMV at a level of the area postrema (0.3 mm rostral to the CS) evoked
a transient increase in IGP, whereas administration of PrRP at the same site produced marked gastric contraction
and evoked phasic increases in IGP (inset shows boxed region at expanded scale). B, administration of L-glutamate
or PrRP into the caudal DMV at a level 0.1 mm posterior to the CS induced gastric relaxation, as evidenced by
decreases in baseline IGP, and inhibited phasic contractions. Both types of gastric motor response to microinjection
of PrRP occurred independently of changes in arterial pressure (A and B, lower traces).
The gastric motor effects produced by microinjection
of PrRP (2 pmol in 20 nl) into different regions of the
DMV were examined in 32 rats. Microinjection of PrRP
into the rostral portion of either the right or left DMV
induced strong gastric contraction, characterized by a
prolonged (8.9 ± 2.2 min, 4–20 min range) increase in IGP
above baseline (4.7 ± 0.8 cm H2O, n = 15, P < 0.01). In all
cases, this was associated with an increase in the frequency
and amplitude of phasic changes in IGP, indicating that
the peptide also stimulated gastric motility (Fig. 1A,
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upper trace and inset). Although PrRP stimulated gastric
contraction when microinjected into the DMV at levels
near the anterior border of the area postrema (five of six
placements located +0.4 to +0.6 mm rostral to the CS,
Fig. 2A), administration of the peptide at more rostral
sites corresponding to the anteriormost extent of the DMV
was without effect (n = 2, data not included in Fig. 2). By
contrast, microinjection of an equivalent amount of PrRP
into the caudal portion of the DMV (0.0 to −0.3 mm
from the CS) induced marked gastric relaxation. The
inhibitory gastric responses to PrRP were characterized by
a sustained decrease in IGP (−4.2 ± 0.6 cm H2O, n = 15,
P < 0.01) that recovered gradually back to the baseline
level, typically within 15 min (9.6 ± 1.5 min) from the
point of peak relaxation (Fig. 1B, upper trace, but see
Fig. 3B). Additionally, in eight cases the gastric relaxation
produced by PrRP was accompanied by attenuation or
complete blockade of phasic changes in IGP (Fig. 1B, lower
trace and Fig. 3B). Microinjection of the vehicle either
before (n = 12) or following administration of the peptide
(n = 18) did not produce significant changes in IGP. On the
other hand, subsequent injections of an identical amount
of PrRP delivered at the same site either in rostral or caudal
portions of the nucleus produced progressively smaller
changes in IGP, indicating tachyphylaxis to the actions of
the peptide. Recovery from tachyphylaxis occurred slowly,
with the amplitude of the gastric motor response to a
second injection of the peptide attaining roughly 70%
of the initial response (79 ± 8% for gastric contraction;
71 ± 6% for gastric relaxation) when 45 min had elapsed
between trials.
The prolonged delay required for complete recovery of
sensitivity to the gastric motor effects of PrRP precluded
accurate determination of dose–response relationships.
In addition, the magnitude of the changes in IGP
produced by microinjection of 2 pmol PrRP into rostral
or cuadal portions of the DMV varied markedly
between placements. Nevertheless, in several of our pilot
experiments (three of five) we were able to evoke an
increase in IGP following microinjection of 0.5 pmol PrRP
(the lowest dose tested) into the rostral DMV at sites
where administration of l-glutamate also evoked gastric
contraction. Furthermore, in a separate group of animals,
administration of 6 pmol (20 nl)−1 PrRP into the DMV
at the level of or caudal to the area postrema evoked
changes in IGP (4.5 ± 1.4 cm H2O, n = 3; and −3.7 ± 1.1,
P < 0.05, n = 2, respectively) comparable in magnitude to
the gastric responses observed following microinjection
of 2 pmol of peptide into corresponding regions of the
nucleus. Thus, 2 pmol of PrRP probably evoked a maximal
response.
Mapping of the microinjection sites in terms of the
response to PrRP indicated that the increases and decreases
in gastric contractility resulted, with rare exception, from
administering the peptide within the confines of the
Figure 2. Summary map showing the location of the sites of
microinjection of PrRP into the DMV at levels corresponding to
the rostral pole of the nucleus (A), the area postrema (B), CS (C)
and caudal pole of the DMV (D)
The approximate location of the DMV is outlined by the solid oval. For
the purposes of this study, the portion of the DMV extending from the
CS to +0.2 mm rostral of the anteriormost border of the area
postrema was taken to define the rostral DMV (A and B) and the
region extending caudally from the CS (C and D) was defined as the
caudal DMV. Numbers in lower right of panels indicate rostral–caudal
distance measured relative to the CS, with the caudalmost tip of the
area postrema set as 0 µm. Upward triangles indicate sites where
microinjection of PrRP increased IGP, whereas downward triangles
indicate sites where IGP was decreased in response to PrRP. Open
circles indicate sites where administration of the peptide did not evoke
changes in IGP. Locations of various NTS subnuclei are not shown for
purposes of clarity. Abbreviations: AP, area postrema; cc, central canal;
CS, calamus scriptorius; HG, hypoglossal nucleus; NG, nucleus gracilis;
NTS, nucleus tractus solitarius; V4, fourth ventricle. Scale bar=300 µm.
C© The Physiological Society 2004
828 G. Grabauskas and others J Physiol 561.3
rostral and caudal DMV, respectively (Fig. 2). These
results appeared to conflict with findings from in situ
hybridization analyses of mRNA for PrRP receptors in
brain, which indicate that these receptors are found in
moderate to high density throughout the NTS and in the
area postrema, but are not expressed in DMV neurones
(Roland et al. 1999; Ibata et al. 2000). Therefore, additional
kinds of experiments were performed to identify the
neuronal substrate(s) and site of action through which
exogenous application of PrRP effected changes in vagal
motor output to the stomach. To determine whether the
PrRP-induced increases in IGP were due to activation of
preganglionic motor neurones in the DMV projecting
to the stomach, ipsilateral vagotomy was performed
in six rats. In five of the experiments, vagotomy was
performed after IGP had returned to the baseline level
and remained stable following the response to an initial
microinjection of 2 pmol of PrRP into the DMV.
In addition, to avoid confounding effects owing to
drug tachyphylaxis, a minimum of 45 min was
allowed following termination of the initial response
to PrRP before administration of the second dose
Figure 3. Representative chart recordings showing gastric contraction (A) and relaxation (B) produced by
microinjection of PrRP into the rostral DMV and caudal portion of the DMV, respectively, and elimination
of the gastric motor response to peptide administration following ipsilateral vagotomy
A, microinjection of PrRP (2 pmol/20 nL) into the rostral portion of the right DMV evoked a marked increase
in IGP. Following ipsilateral vagotomy, administration of PrRP in the same site had no effect on IGP (third trace
from left). Microinjection of the same dose of PrRP into the corresponding site in the DMV on the contralateral
(left) side produced a large increase in IGP despite prior sectioning of the right vagus nerve. B, in another rat,
microinjection of PrRP (2 pmol (20 nl)−1) into the left DMV at the level of the CS induced a sustained decrease in
IGP and inhibited phasic contractions. IGP returned to the baseline level abruptly upon sectioning of the ipsilateral
vagus nerve (second trace from left), whereas a subsequent injection of the peptide at the same site made 45 min
after vagotomy did not affect IGP. In contrast, microinjection of PrRP into a similar location within the caudal DMV
on the contralateral (right) side induced gastric relaxation (trace at far right).
of peptide (see above). In all three cases in which
peptide was administered into the rostal DMV, the
contractile response to a second dose of PrRP was
prevented by ipsilateral vagotomy (peak increase in IGP
was 3.5 ± 1.2 cm H2O before vagotomy and 0.3 ± 0.2 cm
H2O after vagotomy, P < 0.05). However, unilateral
vagotomy did not prevent an increase in IGP (3.9 ± 0.8 cm
H2O, compared to vehicle, P < 0.05) following micro-
injection of an identical dose of peptide into corresponding
sites in the contralateral DMV (Fig. 3A). Similarly, in a
separate group of rats (n = 3), reductions in IGP produced
by administration of PrRP into the caudal DMV were
eliminated after ipsilateral vagotomy (3.3 ± 0.9 cm H2O
before versus 0.3 ± 0.2 cm H2O after, P < 0.05), whereas
this manipulation did not interfere with the ability of the
peptide to induce gastric relaxation when administered on
the contralateral side. The results from such an experiment
are depicted in Fig. 3B. In this animal, microinjection of
PrRP at a site 0.1 mm caudal to the CS evoked a sustained
decrease in IGP lasting beyond 20 min. Despite partial
recovery in phasic contractions, gastric tone remained
depressed 25 min after microinjection of peptide, at which
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time ipsilateral vagotomy was performed, resulting in an
abrupt return of IGP to the baseline level. After waiting 1 h
from the time of initial injection of PrRP, administration
of a second dose of PrRP at the same site in the DMV did
not alter baseline IGP. Taken together, these data indicate
that the PrRP-induced changes in IGP were dependent on
vagal motor pathways and probably resulted from actions
of the peptide within the DMV, rather than in adjacent
structures (Ferreira et al. 2000). Furthermore, the fact that
microinjection of PrRP into the DMV had little or no effect
on mean arterial pressure, as noted above (Fig. 1), suggests
that diffusional spread of the drug from the site of injection
into the adjacent NTS was limited.
The differential gastric motor effects obtained following
microinjection of PrRP into rostral versus caudal regions
of the DMV mirrored the regionally dependent pattern
of gastric stimulation and relaxation produced by
glutamatergic excitation of preganglionic vagal motor
neurones within the corresponding areas (see also
Krowicki et al. 2002). This finding, coupled with failure
to detect mRNA encoding for PrRP receptors in DMV
neurones (Roland et al. 1999; Ibata et al. 2000), led
us to hypothesize that PrRP might affect the activity
Figure 4. Representative chart recordings showing the effects of microinjection of L-glutamate (4 nmol)
and PrRP (2 pmol) into the rostral DMV on IGP (upper traces in paired recordings) and mean arterial
pressure (lower traces) before and when performed following local application of the glutamate
receptor antagonists CNQX (200 pmol) and AP5 (2 nmol)
A and B, microinjection of L-glutamate or PrRP increased IGP without change in blood pressure, and D and E,
the gastric responses evoked by either drug were abolished by prior administration of the glutamate receptor
antagonists. C, microinjection of CNQX + AP5 on their own transiently reduced baseline IGP, after which sufficient
time was allowed for its recovery back to the control level before repeating the administration of L-glutamate or
PrRP. The times shown with each pair of recordings indicate the continuous time course of the experiment and
are referenced to the initial delivery of L-glutamate, denoted as 0 min. F, coronal section of brainstem at the level
of the AP illustrates the injection site (upward triangle) within the DMV (outlined by oval) from which the IGP
responses shown in traces (A–E) were obtained.
of gastric-projecting vagal motor neurones, at least in
part, through modulation of their glutamatergic input. To
examine this hypothesis, we compared the gastric motor
responses evoked by microinjection of the peptide into
the rostral (n = 3) or caudal DMV (n = 3) before and
after local blockade of NMDA-type and non-NMDA-type
glutamate receptors by combined administration of 20 nl
of AP5 (200 pmol) and CNQX (200 pmol), respectively.
To avoid confounding effects associated with tachy-
phylaxis to the peptide (see above), at least one hour
elapsed between termination of the initial response to
PrRP and trials in which the effects of the peptide
were examined following microinjection of the glutamate
receptor antagonists. In addition, gastric responses evoked
by microinjection of l-glutamate (4 nmol in 20 nl) were
concurrently determined to assess the effectiveness of
antagonist administration in preventing excitation of
DMV neurones through postsynaptic glutamate receptors.
In all three experiments in which microinjections were
made into the DMV rostral to the CS, the stimulation
of gastric motor activity produced by microinjection of
PrRP was blocked by prior administration of CNQX
and AP5 (increase in IGP of 2.8 ± 0.15 cm H2O before
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versus 0.1 ± 0.01 cm H2O after CNQX + AP5, P < 0.01).
Concomitant with the blockade of responses to PrRP,
administration of CNQX + AP5 prevented increases in
IGP evoked by microinjection of l-glutamate at the same
site (1.5 ± 0.1 cm H2O before versus 0.1 ± 0.02 cm H2O
after, P < 0.01). The paired traces depicted in Fig. 4,
from a representative experiment, illustrate the effects
on IGP (upper) and mean arterial pressure (lower)
produced by microinjection of PrRP or l-glutamate before
and after administration of the antagonists. Analagous
results were obtained with CNQX and AP5 in a related
series of experiments (n = 3), wherein local blockade
of NMDA- and non-NMDA-type glutamate receptors
prevented the inhibition in gastric motor activity produced
by microinjection of either PrRP or l-glutamate into
the caudal DMV (−2.2 ± 0.85 cm H2O before versus
0.2 ± 0.25 cm H2O after CNQX + AP5, P < 0.05, Fig. 5).
Interestingly, in three of the six animals examined, IGP was
transiently decreased and increased following micro-
injection of CNQX + AP5 into the rostral (n = 2) and
caudal DMV (n = 1), respectively, indicating that the
excitability of gastric-projecting DMV neurones was
Figure 5. Representative chart recordings showing the effects of microinjection of L-glutamate (4 nmol)
and PrRP (2 pmol) into the caudal DMV on IGP (upper traces in paired recordings) and mean arterial
pressure (lower traces) before and following application of the glutamate receptor antagonists CNQX
(200 pmol) and AP5 (2 nmol)
A and B, microinjection of L-glutamate or PrRP decreased baseline IGP and phasic contractions without change in
blood pressure. D and E, the inhibitory effects of both drugs on gastric motor activity were abolished following
administration of the glutamate receptor antagonists, with F, reponses to PrRP showing partial recovery after
40 min. Microinjection of CNQX + AP5 on their own transiently increased baseline IGP, which recovered back to
the control level prior to repeating the administration of L-glutamate or PrRP. The times shown with each pair
of recordings indicate the continuous time course of the experiment and are referenced to the initial delivery of
L-glutamate, denoted as 0 min.
governed in part via a tonically active glutatmatergic input
under our experimental conditions (Figs 4C and 5C).
To further establish that the gastric motor responses
evoked by administration of PrRP into the DMV arose
locally from actions of the peptide within the nucleus, we
examined the gastric motor effects produced by micro-
injection of PrRP into the NTS in a separate group of
animals (n = 7). Administration of the peptide into the
mNTS at sites 0.3–0.6 mm rostral to the CS produced
transient increases in IGP in two rats (0.8 and 3.3 cm
H2O of 1.5 and 5 min duration, respectively), whereas
it had little or no effect on gastric motor function
in three additional animals (Fig. 2B). On the other
hand, microinjection of peptide into the comNTS (0.1
rostral to 0.2 mm caudal to the CS) decreased IGP and
reduced phasic contractions in two rats. Here too, the
changes in IGP were of short duration (lasting 2–3 min)
and much smaller in amplitude (−0.8 and −1.2 cm
H2O) than the gastric responses produced following
administration of PrRP into corresponding portions of
the DMV. Furthermore, in nearly all cases administration
of the peptide into the mNTS or comNTS produced an
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appreciable increase in mean arterial pressure. By contrast,
neither increases nor decreases in IGP, or changes in mean
arterial pressure were observed when PrRP was micro-
injected into the hypoglossal nucleus (n = 3) (Fig. 2).
PrRP indirectly affects excitability
of gastric-projecting DMV neurones
Whole-cell recordings were obtained from identified
vagal motor neurones in rat medullary slices to
investigate the mechanisms by which PrRP acts in the
DMV to modulate gastric motor activity. The effects
of bath administration of PrRP were examined on the
resting membrane properties (n = 30) and synaptically
evoked currents (n = 35) in DMV neurones retrogradely
labelled following placement of DiI to the gastric corpus.
For these experiments, the peptide was administered at a
concentration of 100 or 300 nm, which was determined
in pilot studies to be suprathreshold for evoking changes
in spontaneous firing and modulating the amplitude of
synaptically evoked currents.
Superfusion of medullary slices with PrRP for 1–3 min
increased spontaneous firing in 10 of 30 (33%)
corpus-projecting DMV neurones recorded under current
clamp at −54 mV holding potential. In eight of these
neurones, the PrRP-induced increase in spontaneous firing
was accompanied by a small depolarization (4.6 ± 1.3 mV,
range 2–6 mV, P < 0.05 compared to control) (Fig. 6).
The excitatory effects of PrRP developed slowly, reaching
a peak after 1–3 min, and were of prolonged duration
with recovery to the baseline occurring 15–45 min after
switching the bath perfusate back to control medium.
Repeated applications of the peptide produced similar,
but often less robust effects in the same neurone,
suggesting desensitization of PrRP receptors. On the
other hand, changes in resting membrane potential were
not observed in any of five responsive neurones when
testing of the peptide was performed during blockade
of impulse-dependent synaptic transmission with TTX
(2 µm) (Fig. 6A2). In addition, administration of PrRP
either in the absence or presence of TTX resulted
in little or no change in membrane input resistance
(699 ± 79 M, control versus 721 ± 89 M, n = 13), as
determined by measurement of electrotonic potentials
elicited by injection of constant, hyperpolarizing current
pulses through the recording electrode (Fig. 6B). These
results indicated that the peptide acted indirectly to
modulate activity in DMV neurones via interactions at
presynaptic sites. Interestingly, responsiveness to PrRP
did not appear to vary among neurones sampled from
different regions of the DMV. Thus, the excitatory effects of
PrRP on spontaneous firing were encountered with equal
probability among DMV neurones found at the level of the
area postrema (5 of 16 tested) and those located in more
caudal portions of the DMV (5 among 14 tested).
To determine if the excitation of DMV neurones
by PrRP was dependent on activation of postsynaptic
glutamate receptors, we next examined for sensitivity
of the peptide-induced firing to blockade by selective
antagonists for NMDA- (APV) and non-NMDA-type
(CNQX) glutamatergic receptors. Co-administration of
these glutamate receptor antagonists attenuated the
Figure 6. Representative current-clamp recordings showing
PrRP-induced depolarization and increase in spontaneous firing
in gastric-projecting DMV neurones
A1 (upper trace), superfusion of PrRP (300 nM) produced a small
membrane depolarization, accompanied by a marked increase in
spontaneous discharge that persisted for many minutes following
washout of the peptide. (lower trace). A segment of same recording
displayed at faster time sweep illustrates slowly developing
depolarization of 4 mV in response to PrRP. A2, administration of TTX
(2 µM) blocked spontaneous action potential firing in the same
neurone, and in its presence PrRP had no effect on the membrane
potential or spike discharge. Note different time scales for upper and
lower traces. B, current-clamp recording from another gastric-
projecting DMV neurone showing attenuation of the excitatory effects
of PrRP on membrane potential and spike firing during
coadministration of the glutamate receptor antagonists APV (50 µM)
and CNQX (20 µM). The excitatory effects of PrRP were re-established
and the elevation in spike firing increased further following washout
of APV and CNQX from the bath. Downward deflections in the trace
represent electrotonic potentials evoked in response to the passage of
constant hyperpolarizing current pulses through the electorde that
were used for measurement of membrane conductance. Holding
potential for both neurones was −54 mV. Slow sampling rate of
digitization resulted in truncation in the amplitudes of some action
potentials.
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Figure 7. PrRP enhanced synaptically evoked excitation in DMV neurones
A, pairs of EPSCs were evoked 100 ms apart by delivering two identical electrical stimuli (S1, S2) to the mNTS
before, during administration and after washout of PrRP (300 nM). Superfusion of PrRP increased the amplitude
of the evoked EPSCs (compare S1 response of control and PrRP traces), with recovery of the response back to
control amplitude following 25 min of superfusion with normal Krebs solution (trace labelled wash). In addition,
comparison of the amplitude of the second EPSC with that of the first synaptic current response of the pair revealed
that administration of PrRP altered the paired pulse ratio (S2/S1). B, the alteration of the paired pulse ratio of evoked
EPSCs by PrRP can be observed more readily following normalization of the responses recorded in PrRP to control
amplitude. C, summary histogram of results from 12 experiments illustrating the decrease in ratio of the paired
EPSCs (S2/S1) following administration of PrRP, indicating a presynaptic effect of the peptide. ∗ P < 0.05. Traces in
A and B are the average of responses to 10 stimulus trials. Holding potential was −60 mV. Error bars show S.E.M.
membrane depolarization and eliminated the increase in
spontaneous activity produced by application of PrRP
(n = 6, Fig. 6B). Moreover, the elevation in firing caused
by the peptide resumed after washout of the antagonists,
indicating their actions were likely to be specific and not the
result of tachyphylaxis to PrRP. The results obtained with
Figure 8. Enhancement of synaptically evoked excitation by
PrRP does not reflect changes in postsynaptic sensitivity to
glutamate
A, voltage-clamp recordings from a representative experiment
illustrate enhancement by PrRP of mNTS-evoked EPSCs in a
gastric-projecting DMV neurone. Traces are the average of responses
to 10 stimulus trials. B, PrRP did not affect inward currents evoked in
the same neurone in response to application of the putative excitatory
transmitter L-glutamate (1 mM) to the surface of the slice from an
extracellular glass micropipette. Filled circles indicate the time of
delivery of L-glutamate to the slice by pneumatic pressure ejection.
Holding potential was −60 mV.
these pharmacological antagonists strongly suggest that
the stimulatory effects of PrRP on DMV neurone activity
were mediated indirectly and resulted, at least in part, from
an enhancement of glutamatergic input to the neurones.
Effects of PrRP on EPSCs evoked by NTS stimulation
In additional experiments conducted under voltage-
clamp, we examined the effects of PrRP on postsynaptic
currents evoked by electrical stimulation in the NTS
to determine if the peptide modulated glutamatergic
excitatory synaptic inputs to gastric-projecting DMV
neurones. EPSCs were tested in isolation for modulation
by PrRP by recording in the presence of the GABAA
receptor antagonist BMI (30 µm) or picrotoxin (100 µm).
Bath application of PrRP (100 or 300 nm) produced little
change in resting membrane currents recorded at the
holding potential (−60 mV), but increased the amplitude
of evoked EPSCs by 162 ± 29% (P < 0.05, range 111% to
215%) in 17 of 35 neurones examined, including 10 of 19
and 7 of 16 cells sampled from rostral and caudal portions
of the DMV, respectively (Fig. 7A). Among 12 neurones
examined in which PrRP increased the amplitude of the
evoked EPSC, the ratio (S2/S1) of the EPSCs evoked by two
identical pulses delivered 100 ms apart was decreased from
0.95 ± 0.08 to 0.71 ± 0.11 (P < 0.05) in the presence of the
peptide (Fig. 7C). Such an alteration in the paired-pulse
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ratio is consistent with a presynaptic action of PrRP
(Harris & Cotman, 1983; Trombley & Westbrook, 1992).
In addition, we found that PrRP did not affect inward
currents produced by direct applications of l-glutamate
(1 mm) to the slice via an auxillary pipette (n = 3, Fig. 8).
Thus, it was unlikely that the increase in amplitude of
evoked EPSCs observed during administration of PrRP
resulted from changes in postsynaptic sensitivity to the
excitatory transmitter.
We next examined for an effect of PrRP on spontaneous
EPSCs (sEPSCs) to determine whether the facilitation
of excitatory input onto DMV neurones arose indirectly
from increased firing in glutamatergic NTS neurones or
from presynaptic actions of the peptide on their nerve
terminals. For these experiments, sEPSCs were recorded
at a holding potential of −60 mV in the presence of
BMI (30 µm) from corpus-projecting DMV neurones
in which PrRP enhanced excitation evoked by electrical
stimulation in NTS. Administration of PrRP (300 nm)
reversibly increased sEPSC frequency by 24–191% in six
Figure 9. Presynaptic mechanism for PrRP to facilitate glutamatergic transmission between NTS and
DMV neurones
A, representative current traces from a corpus-projecting DMV neurone show that administration of PrRP (300 nM)
reversibly increased the frequency of spontaneous EPSCs (sEPSCs). Voltage-clamp recordings were obtained at a
holding potential of –60 mV and in the presence of bicuculline methiodide (30 µM) to permit the measurement of
sEPSC activity uncomtaminated by sIPSCs. B, cumulative distributions of interevent intervals (left) and C, histogram
plots of sEPSC amplitude (right) for the same neurone before and during administration of PrRP reveal that
the peptide increased the frequency of sEPSCs, without appreciable change in their amplitude. D, traces from
another corpus-projecting DMV neurone recorded in the presence of TTX (2 µM) and BMI (30 µM) show that the
administration of PrRP (100 nM) increased the frequency of spontaneous mEPSCs. Recordings were made at a
holding potential of –70 mV to facilitate the measurment of these currents by increasing unitary amplitude.
of eight neurones, with mean frequency being increased
by 86 ± 24% (P < 0.01) (Fig 9A and B). The increase
in frequency of sEPSCs was not accompanied by a
significant change in mean amplitude of these post-
synaptic currents (22.9 ± 2.6 pA, control versus 24.8 ±
3.5 pA, PrRP; P > 0.5) (Fig. 9C). Additionally, application
of PrRP in the presence of TTX (2 µm) enhanced
the frequency of action potential-independent miniature
EPSCs (mEPSCs, increased by 24–50%) in two of three
neurones in which sEPSC frequency was increased pre-
viously by PrRP in normal Krebs solution (Fig. 9D). The
finding of increased frequency of sEPSCs (and mEPSCs)
without change in amplitude strongly suggests that PrRP
acted, at least in part, at receptors located on the terminals
of glutamatergic neurones.
Effects of PrRP on excitability of NTS neurones
Results from in situ hybridization studies reveal that
mRNA encoding for PrRP receptors is abundantly
expressed within the caudal NTS (Roland et al. 1999; Lee
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et al. 2000). Thus, it seems plausible that receptors for PrRP
might be expressed postsynaptically in somatodendritic
regions of mNTS or comNTS neurones and play a role
in modulating their excitability. If so, peptide-induced
changes in the excitability and/or impulse activity of NTS
neurones might contribute as well to the ability of PrRP
to modulate spontaneous firing in vagal motor neurones
and facilitate synaptic transmission between the NTS and
DMV. This possibility was examined in a final series of
experiments by determining the effects of PrRP on the
spontaneous firing and intrinsic membrane properties
of a random sample (n = 31) of mNTS and comNTS
neurones. Contrary to expectations, administration of the
peptide (100–300 nm) did not affect spontaneous firing
or alter the membrane potential in any NTS neurones
recorded under current clamp at −60 mV holding
potential (Fig. 10). In addition, PrRP did not alter
membrane conductance in these neurones, as determined
from examination of the current–voltage relationships
generated in the absence and presence of peptide in
response to passage of an incremental series of hyper-
polarizing current pulses through the recording electrode
(Fig. 10). On the basis of these data, we suggest that PrRP
regulates excitability in gastric-projecting vagal motor
neurones primarily by acting presynaptically on the axonal
terminals of glutamatergic neurones to facilitate excitatory
synaptic input to the DMV.
Figure 10. PrRP does not affect postsynaptic
excitability of NTS neurones
A, family of electrotonic potentials recorded in an mNTS
neurone in response to passage of an incremental series
of 200 ms hyperpolarizing and depolarizing current
pulses (shown below) through the recording electrode in
the absence (control) and presence of PrRP (300 nM).
Administration of PrRP had no effect on the membrane
potential and did not alter spontaneous or current-
evoked action potential firing in this cell, or in any of 30
additional NTS neurones examined. B, current–voltage
relationship generated from the responses shown in the
traces above indicates a lack of effect of PrRP on
membrane conductance over a range of membrane
potentials. Neurone was current clamped at –55 mV
holding potential.
Discussion
Stimulation of gastric contraction by PrRP
To the best of our knowledge this report provides the
first evidence that suggests a role for PrRP in the central
control of gastric motor function. The results of our
in vivo experiments in anaesthetized rats indicate that
PrRP evokes marked and prolonged increases in IGP
and stimulates phasic contractions when microinjected
into the rostral DMV at the level of the area postrema.
Conversely, microinjection of the peptide into the caudal
DMV at or slightly posterior to the CS induced pronounced
gastric relaxation and inhibited phasic contractions.
Several lines of evidence indicate that the gastric motor
responses produced following microinjection of PrRP
into the DMV can be attributed to actions of the peptide
within the nucleus, resulting in corresponding changes
in vagally mediated parasympathetic efferent outflow to
the stomach. First, mapping studies demonstrated that the
most effective sites for producing either gastric contraction
or relaxation were located directly in the DMV, albeit in
distinct regions of the nucleus. By contrast, placements of
PrRP slightly outside the boundaries of the DMV either in
the mNTS or comNTS produced weak responses, whereas
those made in the hypoglossal nucleus were without
effect. Second, both the stimulatory and depressant effects
on gastric contractility produced by microinjection of
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PrRP into the DMV occurred independently of changes
in mean arterial pressure. In addition, they were not
mimicked by administration of an identical volume of
saline, indicating the actions were specific and unlikely
to result from diffusion of peptide outside the DMV.
Third, the stimulatory effects of PrRP on gastric motor
function were abolished following ipsilateral vagotomy,
confirming their mediation via vagal efferent pathways.
Earlier results from anatomic tracing studies indicate that
each DMV provides ipsilateral projections to the stomach
(Blessing et al. 1991), whereas neurones of the mNTS send
projections to both the right and left DMVs (Blessing
et al. 1991). Hence, the finding that ipsilateral vagotomy
was sufficient to block the gastric stimulation produced
by microinjection of PrRP in the DMV provides further
evidence that the effects of the peptide were mediated
locally and unlikely to involve changes in the activity
of NTS neurones, per se. Similarly, the fact that the
reductions in IGP produced by microinjection of PrRP
into the caudal DMV were abolished following ipsilateral
vagotomy argues that the inhibitory effects of the peptide
on gastric motor function also derived from actions within
the DMV.
Preganglionic neurones in the DMV that supply the
upper gastrointestinal tract can be functionally partitioned
into a ‘gastro-stimulatory group’ located rostral to the
obex and an ‘inhibitory group’ found in caudal portions
of the nucleus posterior to the obex, where stimulation
results in relaxation of the lower oesophageal sphincter and
gastric smooth muscle (Rossiter et al. 1990; Sivarao et al.
1999; Krowicki et al. 2002). In keeping with this, we found
that glutamatergic stimulation of neurones in the rostral
DMV at the level of the AP produced gastric contraction,
reflected by an increase in IGP, whereas decreases in IGP
occurred following microinjection of l-glutamate into
more caudal portions of the DMV. Others have shown that
the gastric motor responses produced by stimulation of
neurones in the rostral and caudal DMV involve activation
of separate groups of preganglionic vagal neurones that
synapse, respectively, onto postganglionic cholinergic
excitatory elements and non-adrenergic, non-cholinergic
(NANC) inhibitory motor neurones in the gastric wall
(Rossiter et al. 1990; Rogers et al. 1996; Takahashi &
Owyang, 1997). In the present study, microinjection of
PrRP into rostral or caudal portions of the DMV evoked the
same pattern of gastric excitation or relaxation produced
by administration of l-glutamate at that site. Thus, PrRP
may exert its opposing effects on gastric motor function
in the rostral and caudal DMV through activation of
functionally distinct populations of preganglionic vagal
motor neurones involved in cholinergic excitatory and
NANC inhibitory projections to the stomach. Nonetheless,
the results from our electrophysiological experiments
indicate that PrRP does not act directly to regulate the
excitability of gastric-projecting vagal motor neurones, in
contrast to l-glutamate which produces depolarization
and increases firing in gastric-related DMV neurones
via activation of postsynaptic AMPA- and NMDA-type
glutamate receptors (Travagli et al. 1991; Willis et al.
1996; Bertolino et al. 1997). Furthermore, we showed
that local blockade of AMPA- and NMDA-type glutamate
receptors with CNQX and AP5 prevented the gastric
contractions and relaxations produced by microinjection
of PrRP into rostral and caudal DMV, respectively. The
blockade by CNQX and AP5 of responses to PrRP
was probably due to specific antagonism of glutamate
receptors, as evidenced by the concomitant blockade
of gastric motor responses evoked by microinjection of
l-glutamate. Morever, the fact that administration of these
antagonists produced transient reductions (injections into
the rostral DMV) or elevations in baseline IGP (caudal
DMV) is consistent with results from earlier studies which
suggest that gastric-projecting DMV neurones receive
an underlying tonic excitation. (Sivarao et al. 1998). A
reasonable conclusion to be drawn from these data is that
PrRP acts within the DMV to regulate gastrostimulatory
and gastroinhibitory vagal motor outflow by way of an
indirect, glutamatergic-dependent mechanism.
Neuronal target and site of PrRP actions in the DVC
High levels of PrRP, PrRP mRNA and mRNA encoding for
PrRP receptors have been reported in the caudal NTS, AP
and the A1 catecholaminergic cell group in the ventro-
lateral medulla (Roland et al. 1999: Ibata et al. 2000).
Each of these areas sends projections into the DMV
(Rogers et al. 1980; Fukuda et al. 1987), providing an
anatomical substrate whereby endogenous release of PrRP
could modulate the excitability of vagal efferent neurones
that supply the stomach. However, the DMV shows sparse
specific binding sites for PrRP (Roland et al. 1999; Ibata
et al. 2000), and vagal neurones do not express mRNA
encoding for PrRP receptors (Roland et al. 1999; Lee
et al. 2000; Ibata et al. 2000). These considerations suggest
that PrRP may be acting indirectly to alter the activity
of vagal neurones that regulate gastric motor function,
presumably by modulating the level and/or effectiveness
of excitatory afferent input converging on these cells.
In keeping with this, results from brain slice recordings
showed that PrRP produced excitation in a subset of
corpus-projecting DMV neurones, but that these effects
were abolished during blockade of impulse-dependent
synaptic transmission with TTX. In addition, elevations
in spontaneous neuronal firing produced by PrRP were
sensitive to blockade by administration of APV and CNQX,
indicating mediation of these excitatory effects via release
of glutamate and activation of postsynaptic NMDA- and
non-NMDA-type receptors. NTS neurones located in the
subnuclei medialis and commisuralis provide a major
source of excitatory input to the DMV, and electrical
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stimulation within these areas produces glutamatergic
synaptic currents and potentials in a large percentage
of gastric-projecting vagal neurones (Willis et al. 1996;
Browning & Travagli, 2001; Browning et al. 2002; and
this study). Furthermore, Lawrence et al. (2002) have
recently demonstrated using c-fos functional mapping
that neurones in the caudal NTS, which includes these
subnuclei, show marked activation in response to intra-
cerebroventricular administration of PrRP. Thus, NTS
neurones and/or their axonal endings may provide the
neurological substrate whereby the primary actions of
endogenous PrRP in the DVC are transformed into
changes in vagal efferent activity and gastric-directed
outflow.
PrRP modulates NTS-DMV synaptic transmission
Although central administration of PrRP has been shown
to produce marked activation of neurones in caudal NTS,
no significant changes were found in the number of
neurones expressing c-fos in the DMV following these
treatments (Lawrence et al. 2002). Similarly, only a limited
percentage of the DMV neurones (∼33%) recorded under
current-clamp conditions showed increased spontaneous
firing or a depolarizing shift in holding current during
superfusion of brainstem slices with PrRP. On the other
Figure 11. Schematic model depicting the anatomical relationships within rostral and caudal portions of
the DMV whereby PrRP is hypothesized to activate vagal efferent pathways to evoke gastric contraction
and relaxation, respectively
In both cases, specific receptors for PrRP are hypothesized to reside presynaptically on the nerve endings of
glutamatergic NTS neurones, but not on the cell bodies of DMV or NTS neurones. Dotted line denotes approximate
boundary between the NTS and DMV, without reference to anatomical exactness. Note that PrRP is shown to be
colocalized with tyrosine hydroxylase (TH) in NTS neurones of noradrenergic phenotype, comprising the A2 cell
group. Abbreviations: Chol PPN, cholinergic postganglionic parasympathetic neurone; NANC PPN, non-adrenergic,
non-cholinergic postganglionic parasympathetic neurone. Unshaded terminals represent presynaptic elements of
excitatory synapses, whereas darkened terminals represent presynaptic inhibitory elements.
hand, administration of PrRP had marked effects on
postsynaptic responses evoked by activation of excitatory
afferent inputs from the NTS, producing enhancement of
glutamatergic EPSCs in 48% of the corpus-projecting vagal
motor neurones examined. In addition, PrRP altered the
paired pulse ratio for EPSCs evoked by presentation of
two identical NTS stimuli, spaced closely apart, but it did
not affect the responses of DMV neurones to postsynaptic
applications of l-glutamate, the putative excitatory neuro-
transmitter. Such data are consistent with the notion that
PrRP acts via a presynaptic mechanism (see Trombley
& Westbrook, 1992; Travagli & Williams, 1996) within
the DVC to modulate the efficacy of excitatory synaptic
connections between NTS neurones and vagal efferent
neurones that innervate the stomach. This conclusion is
supported further by the fact that in most neurones in
which PrRP altered the paired pulse ratio, administration
of the peptide also increased the frequency without change
in amplitude of spontaneous EPSCs. Furthermore, the
finding in several of these neurones that PrRP increased
the frequency of action potential-independent mEPSCs
strongly suggests that the facilitating effects of the peptide
resulted, at least in part, from actions exerted at receptors
located on glutamatergic nerve terminals.
Lastly, we should add that our inability to demonstrate
direct postsynaptic effects of PrRP in NTS neurones
C© The Physiological Society 2004
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does not preclude the possibility that PrRP might affect
membrane excitability or spike firig indirectly, for example,
by modulating responsiveness to or efficacy in the release
of afferent neurotransmitters. Accordingly, it remains to
be determined whether the PrRP-induced enhancement of
excitatory input into the DMV reflects actions confined to
the nerve terminals of glutamatergic NTS neurones or also
includes more remote effects of the peptide that influence
spike activity in these neurones. Still, the fact that ipsilateral
vagotomy abolished the gastric contraction and relaxation
produced by microinjection of PrRP into the DMV
indicates that the responses themselves are not dependent
on changes in NTS neurone activity. In Fig. 11 we present a
schematic model that depicts the anatomical relationships
within rostral and caudal portions of the DMV whereby
PrRP is hypothesized to activate vagal efferent pathways
to evoke gastric contraction and relaxation, respectively.
In both situations, specific receptors for PrRP are hypo-
thesized to reside presynaptically on the nerve endings of
glutamatergic NTS neurones, rather than on the cell bodies
of DMV or NTS neurones.
Physiological implications of PrRP-induced
modulation of gastric motor function
A remaining issue to consider is how the gastric motor
effects of PrRP demonstrated here might fit within a
wider perspective of the peptide’s postulated involvement
in feeding behaviour and energy balance. Recent reports
have provided strong evidence for a physiological role
for PrRP in the regulation of feeding, particularly with
respect to the signalling of satiety in response to gastro-
intestinal stimuli. In this regard, central administration
of PrRP has been shown to reduce food intake and body
weight in both free-feeding and fasted rats (Lawrence
et al. 2000). In addition, PrRP mRNA is downregulated
in the dorsomedial hypothalamus, NTS and ventrolateral
medulla (VLM) in several rat models of negative energy
balance (Lawrence et al. 2000). It is well established
that signals from the gastrointestinal tract concerned
with satiety are detected by vagal nerve afferents that
project to neurones in the NTS (McCann et al. 1989),
and it is likely that many of these neurones contain
PrRP. Thus, Lawrence et al. (2002) found that a large
number of PrRP immunoreactive neurones in the caudal
NTS are activated by intraperitoneal injection of the
satiety factor cholecystokinin (CCK). These investigators
also showed that central administration of PrRP elicits
a pattern of c-fos activation in brainstem and forebrain
structures closely resembling that produced by peripheral
administration of CCK (also see Rinaman et al. 1993,
1995). Furthermore, all PrRP-containing neurones in the
NTS coexpress tyrosine hydroxylase (Chen et al. 1999;
Ellacott et al. 2002), suggesting that at least some of
them correspond to noradrenergic neurones of the A2
cell groups that convey the satiating actions of CCK to
the hypothalamus (Luckman, 1992; Rinaman et al. 1995)
and stimulate release of oxytocin, leading to reduced
food intake and delayed gastric emptying (Verbalis et al.
1987; Lawrence et al. 2000). The present data provide
evidence that PrRP-containing neurones in the NTS may
also be components of a short-feedback loop, acting in
a regionally specific manner within the DVC to modulate
gastric motility. Conceivably, PrRP might be released from
axonal collaterals of A2 neurones into the DMV (Rea et al.
1982; Fukuda et al. 1987) after feeding, and act locally
either to constrain (rostral of the obex) or augment (caudal
to the obex) the gastro-inhibitory effects produced by
activation of oxytocin-containing input from the hypo-
thalamus. Interestingly, nearly all of the NTS neurones that
contain PrRP have also been shown to express receptors
for leptin (Ellacott et al. 2002). Moreover, their anatomical
location in close proximity to the AP may enable them to
monitor leptin concentrations in the blood plasma, owing
to the lack of a blood–brain barrier in this area. These
considerations lead us to suggest an alternative possibility
that the effects produced by actions of PrRP within the
DMV may have little to do with events surrounding feeding
episodes per se, but instead provide a mechanism for
adjusting the level of parasympathetic autonomic outflow
in accordance with nutrient intake to maintain energy
homeostasis.
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